Insider Transactions
Real-Time tracking of corporate insider buying and selling activity
Last updated
8/26/2026, 5:31:59 PM
Total Transactions
46
Total Value
$65,484,362
Average Value
$1,423,573
Buy/Sell Ratio
29/13
Value Distribution
Top Transactions by Value
BABA
Multiple
$25,691,200
Aug 25
SUJA
Paine
$5,723,741
Aug 21
HCC
Scheller
-$5,500,000
Aug 24
Most Active Companies
View allTransactions
4
Total Value
$6,662,908
Net Value
$0
Transactions
2
Total Value
$1,331,653
Net Value
$1,331,653
Transactions
2
Total Value
$1,497,398
Net Value
$1,497,398
Transactions
2
Total Value
$2,759,900
Net Value
$2,759,900
Transactions
2
Total Value
$384,144
Net Value
$384,144
Transactions
2
Total Value
$331,518
Net Value
-$331,518
Transactions
1
Total Value
$461,368
Net Value
$461,368
Transactions
1
Total Value
$489,360
Net Value
$489,360
Most Active Insiders
View allTransactions
10
Total Value
$33,466,757
Transactions
2
Total Value
$79,798
Transactions
2
Total Value
$6,583,110
Transactions
1
Total Value
$556,800
Transactions
1
Total Value
$30,271
Transactions
1
Total Value
$51,946
Transactions
1
Total Value
$167,426
Transactions
1
Total Value
$154,403
Recent Transactions
View allAMRZ
Amrize Ltd
Aug 11
Insider
Multiple Insiders
8 Insiders
Price
$46
Shares
25,338
Value
$1,177,250
PRE
Prenetics Global Ltd
Aug 24
Insider
Multiple Insiders
2 Insiders
Price
$21
Shares
47,781
Value
$999,698
TTMI
Ttm Technologies Inc
Aug 25
Insider
Multiple Insiders
2 Insiders
Price
$109
Shares
15,000
Value
$1,642,200
BCML
Baycom Corp
Aug 21
Insider
Multiple Insiders
3 Insiders
Price
$30
Shares
15,250
Value
$461,368
TISI
Team Inc
Aug 21
Insider
Multiple Insiders
4 Insiders
Price
$21
Shares
23,250
Value
$489,360
Our Reports & In-Depth Analysis
Comprehensive, research-backed financial reports with infographics on institutional trends, AI circular flows, and market indicators.
The AI Circular Valuation Bubble: Inside the Venture-Cloud Loop
An in-depth investigation into how technology giants and AI startups engage in circular capital flows, investing venture capital in exchange for cloud services and hardware, creating a closed-loop economy that artificially inflates valuations.
The Biotech Executive Playbook: Tracking Clinical Phase SEC Filings
An empirical study on how clinical-stage biotech executives execute Form 4 open-market purchases ahead of trial data releases, outlining the regulatory gaps and alpha potential of clinical insider tracking.
The Spinoff Separation: Tracking Post-Spinoff Executive Ownership Trends
An investigation of corporate spinoffs, showing how executive equity allocations and post-separation insider transactions signal parent and subsidiary performance trajectories.